Medicure Inc. (OTCMKTS:MCUJF – Get Free Report)’s share price crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.73 and traded as low as $0.63. Medicure shares last traded at $0.63, with a volume of 800 shares.
Medicure Stock Performance
The company has a current ratio of 1.87, a quick ratio of 1.42 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $6.57 million, a PE ratio of -3.50 and a beta of 0.98. The firm’s 50-day simple moving average is $0.73 and its two-hundred day simple moving average is $0.76.
Medicure (OTCMKTS:MCUJF – Get Free Report) last issued its quarterly earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. The business had revenue of $3.78 million for the quarter. Medicure had a negative net margin of 12.46% and a negative return on equity of 12.72%.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
See Also
- Five stocks we like better than Medicure
- 3 Tickers Leading a Meme Stock Revival
- Intel: Is Now the Time to Be Brave?Â
- How to Capture the Benefits of Dividend Increases
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
